AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript : vim

AZN earnings call for the period ending March 31, 2024.

Related Keywords

United States , Cambridge , Cambridgeshire , United Kingdom , San Diego , California , China , Japan , Morgan Stanley , James Gordon Jpmorgan , Pulmicort Flexator , Sandy Barnett , Christopher Uhde , Eric Le Berrigaud , Pascal Soriot , Mark Purcell Morgan Stanley , Luisa Hector Berenberg , Andrew Berens Leerink , James Gordon , Mattias Haggblom , Seamus Fernandez Guggenheim , Amolyt Pharma , Simon Baker Redburn , Marc Dunoyer , Mattias Haggblom Handelsbanken , Sachin Jain , America Merrill Lynch , Seamus Fernandez , Richard Parkes Exane , Biopharmaceuticals Research , Sachin Jain Bank , Astrazeneca , Eric Le Berrigaud Stifel Financial Corp , Tim Anderson Wolfe Research Analyst , Sachin Jain At Bank , Amgen , Fusion Pharmaceuticals , Astrazeneca Plc , Company Analyst , Oncology Research , Central Europe , Annual General Meeting , Vice President , Rare Disease , Executive Officer , Chief Strategy Officer , Investor Day , Tim Anderson , Capital Markets , Mark Purcell , Middle East , Enskilda Banken , Steve Scala , Simon Baker , Andrew Berens , Luisa Hector , Guggenheim Partners , Wolfe Research , Executive Vice President , Skandinaviska Enskilda Banken , Stifel Financial ,